Congo Initiates Trial for Ebola Treatment Targeting Bundibugyo Virus
A new clinical trial has commenced in the Democratic Republic of Congo. The study evaluates a drug designed to combat the Bundibugyo virus, an Ebola strain for which no approved vaccine or treatment currently exists. This initiative marks one of several efforts to address the ongoing outbreak.
GOMA, Democratic Republic of Congo – A clinical trial began in July to test a drug specifically designed to combat the Bundibugyo virus. This particular strain of Ebola has caused the ongoing outbreak in the region. Currently, no approved vaccine or treatment exists for the Bundibugyo virus.
Researchers launched the trial as one of multiple studies underway. These studies aim to identify protective measures and methods to slow the progression of the outbreak.
Related Topics
Article Ratings
How do you feel about this story?
National Desk
Sign in to follow this author from their profile.
Discussion (0)
Join the Conversation
Join the conversation
Sign in to share your thoughts, reply to readers, and like comments.
No comments yet. Be the first to comment!